Pharmafocus Europe

March 12, 2007
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Pharmafocus

Pharmafocus Europe is a new publication set to become an indispensable business tool for pharmaceutical industry executives with an interest …

Shire dispels doubts about New River acquisition

March 12, 2007
Sales and Marketing

Shire has dismissed claims its acquisition of New River Pharmaceuticals is in doubt, after reports that a rival bid for …

Making your mark in 100 days

March 12, 2007
Business Services management, recruitment

Congratulatons, you've got the job – you're a senior executive – maybe even the chief executive officer. It's the opportunity …

NICE judges Tarceva too expensive for NHS

March 9, 2007
Sales and Marketing Tarceva, lung cancer

Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …

Huntsworth makes US acquisition

March 9, 2007
Medical Communications

Communications group Huntsworth Health has acquired US agency Dorland Global Corporation, extending its reach into the world's largest pharmaceutical market.Dorland …

Doctors reassured by hospital reconfiguration report

March 9, 2007

The BMA has said it is "reassured" by Sir Ian Carruthers' report on hospital reconfiguration – the controversial measure which …

Trading Places

March 9, 2007
Business Services, Medical Communications, Sales and Marketing AstraZeneca, Athena, public relations, recruitment

Athena Medical PR and AstraZeneca UK have joined forces to undertake a ground-breaking secondment initiative to help build broader expertise …

PM hints pharma could avoid ‘value-based’ pricing

March 9, 2007
Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing

 Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …

GSK to test Tycerb for head and neck cancer

March 7, 2007
Sales and Marketing breast cancer

GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …

Merck lung cancer vaccine enters phase III trials

March 7, 2007
Research and Development

A therapeutic vaccine for the most common form of lung cancer has enrolled its first patient into global phase III …

Academy launched to fill NHS training need

March 7, 2007
NHS

Training and development company Excel Communications has launched a new initiative to allow pharma companies to sponsor courses for doctors.The …

Eisai prepares for Inovelon UK launch

March 7, 2007
Sales and Marketing

Eisai is preparing to launch its new epilepsy treatment Inovelon in the UK after European regulators approved it in January.Managing …

Work begins on Eisai’s Knowledge Centre

March 7, 2007
Research and Development, Sales and Marketing

Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …

Pfizer’s controversial new UK supply chain goes live

March 5, 2007
Manufacturing and Production

Pfizer has launched its new single wholesaler supply chain in the UK, after a last-minute legal challenge was defeated.The pharmaceutical …

PR: messages from the frontline

March 5, 2007
Medical Communications, Sales and Marketing public relations, strategy

Media rationalisation & technology"Here is the news but not as we know it! The media landscape is constantly evolving as …

Prime Minister opens Amgen European R&D centre

March 2, 2007
Research and Development

Prime Minister Tony Blair has opened Amgen's new European Development Centre in Uxbridge, London.The centre is the Californian biotech company's …

Sales data specialists Cegedim to buy rivals Dendrite

March 2, 2007
Sales and Marketing Cegedim

French specialist pharmaceutical database and software company Cegedim is to buy its US-based rivals Dendrite for $751 million.Dendrite's board of …

New clinical trials network to boost patient recruitment in UK

March 2, 2007
Research and Development

Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …

Novartis’ 2-in-1 blood pressure drug Exforge launched in the UK

March 2, 2007
Sales and Marketing

Novartis new hypertension drug Exforge has been launched in the UK, promising to help more patients lower their blood pressure …

Court orders withdrawal of generic Lipitor in Denmark

March 2, 2007
Sales and Marketing

Pfizer has gained a court injunction ordering the withdrawal of a generic version of its top-seller Lipitor (atorvastatin).Indian generics company …

The Gateway to Local Adoption Series

Latest content